GENinCode Raises £3.9m via Discounted Placing and Director-Backed Subscription

GENinCode UK Ltd. ( (GB:GENI) ) has shared an announcement.

GENinCode plc has conditionally raised £3.9 million before expenses through a heavily discounted placing and subscription of 388,145,000 new ordinary shares at 1p each, a 47.4% discount to the prior closing price. The fundraising, which includes meaningful participation from several directors subscribing for an aggregate 23 million shares, remains subject to shareholder approval at a general meeting scheduled for 9 February 2026 and to the admission of the new shares to trading on AIM, expected around 11 February 2026. A separate retail offer is running in parallel, with its outcome to be announced later, and full take-up would leave the company with 725,027,042 shares in issue, underscoring significant equity dilution but strengthening GENinCode’s capital position to support its ongoing operations and growth plans.

The most recent analyst rating on (GB:GENI) stock is a Sell with a £1.50 price target. To see the full list of analyst forecasts on GENinCode UK Ltd. stock, see the GB:GENI Stock Forecast page.

Spark’s Take on GB:GENI Stock

According to Spark, TipRanks’ AI Analyst, GB:GENI is a Neutral.

The score is held down primarily by weak financial performance (ongoing losses, negative operating cash flow, and declining equity). Technicals add pressure as the stock trades below major moving averages with negative MACD, while valuation is constrained by negative earnings and no dividend yield data.

To see Spark’s full report on GB:GENI stock, click here.

More about GENinCode UK Ltd.

GENinCode plc is a UK-based medical diagnostics company listed on AIM, focused on genomic risk assessment for cardiovascular disease and related conditions. The company develops and commercialises advanced genetic tests aimed at improving the prediction and prevention of cardiovascular events, targeting both clinical and primary care markets in the UK and internationally.

Average Trading Volume: 827,003

Technical Sentiment Signal: Strong Sell

Current Market Cap: £5.45M

See more data about GENI stock on TipRanks’ Stock Analysis page.